Lombard Odier Asset Management (Switzerland)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-79,298
| Closed | -$2.96M | – | 308 |
|
|
2023
Q1 | $2.96M | Buy |
79,298
+18,294
| +30% | +$682K | 0.26% | 92 |
|
|
2022
Q4 | $2.13M | Hold |
61,004
| – | – | 0.17% | 117 |
|
|
2022
Q3 | $3.41M | Sell |
61,004
-4,312
| -7% | -$241K | 0.29% | 80 |
|
|
2022
Q2 | $3.38M | Sell |
65,316
-13,773
| -17% | -$713K | 0.29% | 84 |
|
|
2022
Q1 | $5.75M | Sell |
79,089
-34,222
| -30% | -$2.49M | 0.45% | 60 |
|
|
2021
Q4 | $13.4M | Sell |
113,311
-35,495
| -24% | -$4.2M | 0.86% | 45 |
|
|
2021
Q3 | $20M | Sell |
148,806
-6,395
| -4% | -$858K | 1.24% | 38 |
|
|
2021
Q2 | $25.1M | Sell |
155,201
-127,752
| -45% | -$20.7M | 1.27% | 26 |
|
|
2021
Q1 | $22.7M | Buy |
+282,953
| New | +$22.7M | 1.51% | 21 |
|